214 results
8-K
DRRX
Durect Corp
7 Nov 23
DURECT Corporation Announces Topline Results from Phase 2b AHFIRM Trial
4:10pm
release and the materials to be used in the presentation are filed hereto as Exhibit 99.1 and Exhibit 99.2, respectively, to this Form 8-K
8-K
EX-10.1
rlv vgl44e
21 Jul 23
DURECT Corporation Announces $15 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
5:13pm
424B5
oy19j m2aj7q7m32y1o
21 Jul 23
Prospectus supplement for primary offering
10:38am
DEFA14A
ss1r6o03xykuae5i7bj
27 Apr 23
Additional proxy soliciting materials
4:40pm
DEFA14A
vin67px4
7 Oct 22
Additional proxy soliciting materials
5:04pm
DEFA14A
l9dpt6dh21 75bxi
25 Apr 22
Additional proxy soliciting materials
5:10pm